Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

Hypoxia inducible factor as a cancer drug target.

Welsh SJ, Powis G.

Curr Cancer Drug Targets. 2003 Dec;3(6):391-405. Review.

PMID:
14683498
3.

HIF-1 and tumor progression: pathophysiology and therapeutics.

Semenza GL.

Trends Mol Med. 2002;8(4 Suppl):S62-7. Review.

PMID:
11927290
4.

Hypoxia inducible factor pathways as targets for functional foods.

Losso JN, Bawadi HA.

J Agric Food Chem. 2005 May 18;53(10):3751-68. Review.

PMID:
15884793
5.

Hypoxia-induced angiogenesis during carcinogenesis.

Choi KS, Bae MK, Jeong JW, Moon HE, Kim KW.

J Biochem Mol Biol. 2003 Jan 31;36(1):120-7. Review.

PMID:
12542982
6.

New anticancer strategies targeting HIF-1.

Yeo EJ, Chun YS, Park JW.

Biochem Pharmacol. 2004 Sep 15;68(6):1061-9. Review.

PMID:
15313402
7.

Hypoxia-inducible factor-1 in human breast and prostate cancer.

Kimbro KS, Simons JW.

Endocr Relat Cancer. 2006 Sep;13(3):739-49. Review.

8.

HIFs and tumors--causes and consequences.

Höpfl G, Ogunshola O, Gassmann M.

Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R608-23. Review.

9.

Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).

Nagle DG, Zhou YD.

Curr Drug Targets. 2006 Mar;7(3):355-69. Review.

Supplemental Content

Support Center